首页> 外文期刊>The Journal of arthroplasty >Predictions on preserving bone mass in knee arthroplasty with bisphosphonates.
【24h】

Predictions on preserving bone mass in knee arthroplasty with bisphosphonates.

机译:用双膦酸酯类药物在膝关节置换术中保留骨质的预测。

获取原文
获取原文并翻译 | 示例
           

摘要

Using a computational model of bone adaptation, we investigated the long-term ability of bisphosphonates to minimize proximal bone loss that is associated with stress shielding in the tibia after long-stemmed total knee arthroplasty (TKA). When invoking bisphosphonate effects, the remodeling activity was suppressed, and the resorption size was reduced. Compared with the untreated simulation, bisphosphonate slowed the rate of bone loss after TKA (42% reduction in bone loss at 1 year). Activating the drug 3 months before the surgery reversed bone loss associated with the reduction in such activities as walking, but it did not provide any substantial benefit in the long-term. Late bisphosphonate treatment did not reverse the bone loss that occurred 3.5 years after TKA, although it preserved 3% of bone normally lost without treatment.
机译:使用骨骼适应的计算模型,我们研究了双膦酸盐在长期梗阻全膝关节置换术(TKA)后,与胫骨应力屏蔽相关的近端骨质丢失的长期能力。当调用双膦酸酯作用时,重塑活性被抑制,并且吸收尺寸减小。与未经处理的模拟相比,双膦酸盐减缓了TKA后的骨质流失速度(1年时骨质流失减少42%)。手术前3个月激活该药物可逆转与行走等活动减少相关的骨质流失,但从长远来看并没有提供任何实质性的益处。晚期双膦酸盐治疗并不能逆转TKA发生3.5年后的骨质流失,尽管它保留了正常情况下未经治疗的3%骨质流失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号